|
|
|
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
ÇѼ¾»ç¾÷´ë»óÀÚ ºóÇ÷ ¾ç»ó ºÐ¼® |
|
|
|
|
ÀúÀÚ |
±èÁ¾ÇÊ, ¹ÚÁø¸ð, ÀÌÀÏȯ, ¹ÚÇýÀ± |
¼Ò¼Ó |
Çѱ¹ÇѼ¾º¹ÁöÇùȸ ¿¬±¸¿ø |
|
|
³âµµ |
2019 |
±Ç |
52 |
|
|
È£ |
1 |
¹øÈ£ |
2 |
|
|
½ÃÀÛÆäÀÌÁö |
9 |
³¡ÆäÀÌÁö |
16 |
|
|
÷ºÎ |
ÇѼ¾»ç¾÷´ë»óÀÚ ºóÇ÷ ¾ç»ó ºÐ¼®.pdf |
|
|
¿ä¾à |
In this study, we found that the prevalence of anemia in the persons affected leprosy aged over 60 years was higher than other past reports of general population over 60 years in Korea. So we will consider about the evaluation of higher prevalence of anemia in persons affected leprosy, causes of anemia, especially dapsone-related & other underline disease and management plan for anemia in them by the in-depth studies.
▪ Key Words : anemia, persons affected leprosy |
|
|
³»¿ë |
|
| |
¡¡ |
|
|
|
|
|
|
|
|